Biocon Liberal bonus

Biocon rose 4.91% to Rs 529.65 at 10:45 IST on BSE after its board recommended bonus issue in the ratio of 1:1.

It also announced its Q4 results today.

The stock hit a high of Rs 551.50 and a low of Rs 494.85 so far during the day. The stock had a 52-week high of Rs 663.30 on 15 November 2007 and a 52-week low of Rs 345 on 22 January 2008.

From its recent low of Rs 429.10 on 8 April 2008 stock rose 17.65% to Rs 504.85 on 21 April 2008.

The company’s current equity is Rs 50 crore. Face value per share is Rs 5.

The current price of Rs 529.65 discounts its Q3 December 2007 annualised EPS of Rs 113.61, by a PE multiple of 4.66.

The company’s net profit rose 31.19% to Rs 62.03 crore on 1.96% decline in total income to Rs 236.71 crore in Q4 March 2008 over Q4 March 2007.

Biocon is India's leading biotechnology enterprise. Over the past 28 years, it has evolved from an enzyme manufacturing company to a fully integrated biopharmaceutical enterprise, focused on healthcare.